Editas Medicine to present at investor conferences in September.
ByAinvest
Wednesday, Aug 27, 2025 9:03 am ET1min read
EDIT--
The conferences include the Wells Fargo Healthcare Conference on September 3 in Boston, the Cantor Global Healthcare Conference on September 4 in New York, and the Baird Global Healthcare Conference on September 9 in New York. These events provide investors with an opportunity to engage with Editas Medicine's management team and gain insights into the company's pipeline and future plans.
Editas Medicine's participation in these conferences follows its recent strong performance, as highlighted by a robust 34% week-to-date increase in its share price. The company's second-quarter earnings report, released on Tuesday, showed revenue of slightly under $3.6 million, up from $513,000 in the same quarter last year. Although the company missed earnings expectations, its operational update and future outlook drove investor enthusiasm [1].
The company's CEO, Gilmore O'Neill, stated that Editas is "driving toward our goal of nominating our first in vivo development candidate, which we plan to select in September." This announcement was a significant driver of the stock's performance and generated excitement among investors [1].
Investors interested in Editas Medicine's presentations and one-on-one meetings can access the live webcasts (where available) by visiting the "Investors" section of the company's website at www.editasmedicine.com. An archived replay will be available for approximately 30 days following each event.
References:
[1] https://www.aol.com/why-editas-medicine-stock-skyrocketing-115043661.html
[2] https://www.marketscreener.com/news/editas-medicine-to-participate-in-upcoming-investor-conferences-ce7c50dedc81ff23
Editas Medicine, a gene editing company, announced management participation in three upcoming investor conferences in September. The conferences include the Wells Fargo Healthcare Conference, Cantor Global Healthcare Conference, and Baird Global Healthcare Conference. Editas Medicine's presentations and one-on-one meetings will be available via webcast on the company's website.
Editas Medicine, Inc. (NASDAQ: EDIT), a pioneering gene editing company focused on developing transformative medicines for serious diseases, has announced its management team's participation in three upcoming investor conferences in September. The company's presentations and one-on-one meetings will be available via webcast on the company's website.The conferences include the Wells Fargo Healthcare Conference on September 3 in Boston, the Cantor Global Healthcare Conference on September 4 in New York, and the Baird Global Healthcare Conference on September 9 in New York. These events provide investors with an opportunity to engage with Editas Medicine's management team and gain insights into the company's pipeline and future plans.
Editas Medicine's participation in these conferences follows its recent strong performance, as highlighted by a robust 34% week-to-date increase in its share price. The company's second-quarter earnings report, released on Tuesday, showed revenue of slightly under $3.6 million, up from $513,000 in the same quarter last year. Although the company missed earnings expectations, its operational update and future outlook drove investor enthusiasm [1].
The company's CEO, Gilmore O'Neill, stated that Editas is "driving toward our goal of nominating our first in vivo development candidate, which we plan to select in September." This announcement was a significant driver of the stock's performance and generated excitement among investors [1].
Investors interested in Editas Medicine's presentations and one-on-one meetings can access the live webcasts (where available) by visiting the "Investors" section of the company's website at www.editasmedicine.com. An archived replay will be available for approximately 30 days following each event.
References:
[1] https://www.aol.com/why-editas-medicine-stock-skyrocketing-115043661.html
[2] https://www.marketscreener.com/news/editas-medicine-to-participate-in-upcoming-investor-conferences-ce7c50dedc81ff23
Stay ahead of the market.
Get curated U.S. market news, insights and key dates delivered to your inbox.
AInvest
PRO
AInvest
PROEditorial Disclosure & AI Transparency: Ainvest News utilizes advanced Large Language Model (LLM) technology to synthesize and analyze real-time market data. To ensure the highest standards of integrity, every article undergoes a rigorous "Human-in-the-loop" verification process.
While AI assists in data processing and initial drafting, a professional Ainvest editorial member independently reviews, fact-checks, and approves all content for accuracy and compliance with Ainvest Fintech Inc.’s editorial standards. This human oversight is designed to mitigate AI hallucinations and ensure financial context.
Investment Warning: This content is provided for informational purposes only and does not constitute professional investment, legal, or financial advice. Markets involve inherent risks. Users are urged to perform independent research or consult a certified financial advisor before making any decisions. Ainvest Fintech Inc. disclaims all liability for actions taken based on this information. Found an error?Report an Issue
Comments
No comments yet